![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/51 | |
A61P 35/00 |
(11) | Number of the document | 3344251 |
(13) | Kind of document | T |
(96) | European patent application number | 16774458.0 |
Date of filing the European patent application | 2016-09-05 | |
(97) | Date of publication of the European application | 2018-07-11 |
(45) | Date of publication and mention of the grant of the patent | 2021-04-28 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2016/070888 |
Date | 2016-09-05 |
(87) | Number | WO 2017/037298 |
Date | 2017-03-09 |
(30) | Number | Date | Country code |
201515716 | 2015-09-04 | GB | |
201515712 | 2015-09-04 | GB | |
201515714 | 2015-09-04 | GB | |
201515718 | 2015-09-04 | GB | |
201562217346 P | 2015-09-11 | US | |
201562217332 P | 2015-09-11 | US | |
201605583 | 2016-04-01 | GB | |
201608660 | 2016-05-17 | GB |
(72) |
LINDMARK, Bertil, SG
OOI, Lisa, SG
|
(73) |
Aslan Pharmaceuticals PTE Limited,
10-A Bukit Pasoh Road, 089824,
SG
|
(54) | A COMBINATION THERAPY COMPRISING VARLITINIB AND AN ANTICANCER AGENT |
A COMBINATION THERAPY COMPRISING VARLITINIB AND AN ANTICANCER AGENT |